Earnings Call Intelligence Subscribe
Management credibility scorecard

Procter & Gamble (PG)

5 quarters tracked (Q4'25 to Q4'26) · latest call July 29, 2026
Get the next PG call sheet
81%
Kept of 21 resolved
17
Kept or exceeded
4
Missed
11
Still pending
Share count, 3 yrs/yr · flat

Score History

QuarterCall dateDisclosureFinancial qualityKeptMissed
Q4'26July 29, 20266/121 high, 4 medium, 2 low flags32Call sheet →
Q3'26April 24, 202610/124 medium, 2 low flags40Call sheet →
Q2'262026-01-228/123 medium, 4 low flags40Call sheet →
Q1'26October 24, 202510/123 medium, 4 low flags30Call sheet →
Q4'252025-07-299/121 high, 4 medium, 3 low flags32Call sheet →
Disclosure: the 6-item rubric, each scored 0-2, out of 12. Financial quality: flagged indicators by severity. Kept and missed count the prior-quarter promises scored on that call.

Promise Ledger · All Quarters

MarkedStatusPromise
Q4'26PendingComplete 15% non‑manufacturing headcount reduction over two years
Half of reductions already executed; timeline still FY27‑28.
Q4'26DeliveredFull‑year core EPS growth 0‑4% YoY
Core EPS up 1% FY26, within guidance range.
Q4'26DeliveredMaintain dividend growth (3% increase YoY)
Dividend increased from $2.5 bn (Q3) to $2.6 bn (Q4).
Q4'26ExceededAdjusted free cash flow productivity 85‑90% FY26
Q4 productivity jumped to 133% (though driven by working‑capital timing).
Q4'26MissedGlobal market‑share improvement in FY26
Q4 described as “in line” with prior year; down from “improved” in Q3.
Q4'26MissedOrganic sales >3% YoY for FY26
Delivered only +1% YoY; Q4 flat after pull‑forward adjustment.
Q3'26PendingAdjusted free cash flow productivity in range of 85-90% for year
Q3 at 82% below target range, needs improvement in Q4 to hit guidance
Q3'26DeliveredCore EPS growth of in line to +4% vs prior year ($6.83 to $7.09)
Range maintained but now expecting toward lower end due to cost timing
Q3'26DeliveredAround 2% global market growth for portfolio footprint on value basis
Confirmed underlying market growth with positive trend over last 2 months
Q3'26DeliveredContinue to expect modestly higher interest expense vs last fiscal year
Guidance unchanged and tracking as expected
Q3'26DeliveredOrganic sales growth of in line to +4% for FY26
Guidance range maintained despite cost headwinds, though now expecting lower end
Q3'26PendingStronger results in second half enabling maintained fiscal 2026 guidance ranges
Q3 delivered but now guiding Q4 lower than Q3, mixed delivery on back-half acceleration
Q2'26PendingInnovation investments to drive trial and user growth
Investments made but user growth still described as 'slow' or 'flat'
Q2'26DeliveredChina momentum to continue
Delivered 3% growth as expected, though decelerated from 5% in Q1
Q2'26DeliveredRestructuring progress on track
Confirmed 'perfectly on track on all elements' with org designs completed
Q2'26DeliveredBaby Care innovation bundle in fall
First phase executed, second phase coming as promised
Q2'26DeliveredTide EVO national launch preparation
Now adding manufacturing capacity as promised, retailer demand exceeded expectations
Q2'26PendingReturn to share growth by end of fiscal year
Language softened from 'expect' to 'objective' but still maintained
Q2'26PendingExpect stronger growth in back half of fiscal year
Maintained this promise from Q1, now hanging guidance maintenance on this claim
Q1'26DeliveredRestructuring 'perfectly on track on all elements'
Andre confirmed execution proceeding as planned across all three components
Q1'26DeliveredLaunch Tide evo national expansion
Online launch of Free & Gentle completed, adding manufacturing capacity
Q1'26ExceededSequential improvement in China business
Delivered 5% growth vs 2% prior quarter, accelerating momentum
Q1'26Pending$15 billion cash return to shareholders in fiscal '26
Q1 returned $3.8B, on pace for annual target
Q1'26PendingAdjusted free cash flow productivity of 85% to 90% for fiscal '26
Q1 delivered 102%, above range but expected to normalize
Q1'26PendingCore EPS growth in line to plus 4% ($6.83 to $7.09) for fiscal '26
Q1 delivered 3% growth, slightly below midpoint but tracking
Q1'26PendingOrganic sales growth of in line to plus 4% for fiscal '26
Q1 delivered 2%, at low end of range but within guidance
Q4'25PendingBalance top and bottom line growth over 2-3 years
FY25 delivered but FY26 guidance suggests continued pressure
Q4'25MissedMaintain market share despite consumer pressure
Lost 20bps global share in Q4, first notable decline
Q4'25DeliveredFocus on productivity to fund investments
560bps productivity in Q4, enabling restructuring investment
Q4'25ExceededChina sequential improvement trajectory
Turned positive at +2% with strong brand performance
Q4'25DeliveredContinue strong investment in innovation despite volatility
Maintained innovation pipeline, 7 rising stars vs 3 last year
Q4'25MissedCategory growth rates return to 3-4% (Q3: 'We expect markets to return to the 3% to 4% growth rate')
Now guiding flat to 3% for FY26, acknowledged sustained weakness
Each row is a promise from the prior call, scored against the quarter in "Marked". Kept-promise rate counts resolved promises only; pending is excluded.
Promise-kept rate counts resolved promises only (pending excluded).
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.